Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 13 publications
(20 reference statements)
0
1
0
Order By: Relevance
“…Combination therapy with PRP and ranibizumab showed a potential benefit of preserving contrast sensitivity compared to PRP monotherapy in patients without HR-PDR. [34] The present study demonstrated that PRP + aVEGF was superior to PRP monotherapy in treating HR-PDR patients. Although there were no significant differences in the change of BCVA and FLA as well as the risks of vitreous hemorrhage and other complications between the 2 groups, the change of CMT and rate of undergoing vitrectomy were markedly decreased in PRP + aVEGF group.…”
Section: Discussionmentioning
confidence: 66%
“…Combination therapy with PRP and ranibizumab showed a potential benefit of preserving contrast sensitivity compared to PRP monotherapy in patients without HR-PDR. [34] The present study demonstrated that PRP + aVEGF was superior to PRP monotherapy in treating HR-PDR patients. Although there were no significant differences in the change of BCVA and FLA as well as the risks of vitreous hemorrhage and other complications between the 2 groups, the change of CMT and rate of undergoing vitrectomy were markedly decreased in PRP + aVEGF group.…”
Section: Discussionmentioning
confidence: 66%